Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Drug Screening Assays, Antitumor MeSH Descriptor Data 2025


MeSH Heading
Drug Screening Assays, Antitumor
Tree Number(s)
E01.370.225.500.388
E05.200.500.388
E05.242.417
E05.337.550.200
Unique ID
D004354
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004354
Annotation
IM when general; NIM when with specific antineoplastic agent (IM)
Scope Note
Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.
Entry Term(s)
Anti-Cancer Drug Screens
Anticancer Drug Sensitivity Tests
Antitumor Drug Screening Assays
Antitumor Drug Screens
Cancer Drug Tests
Drug Screening Tests, Tumor-Specific
Dye Exclusion Assays, Antitumor
Tumor-Specific Drug Screening Tests
Previous Indexing
Antineoplastic Agents or specific (1966-1987)
Cell Line (1971-1987)
Colony-Forming Units Assay (1979-1987)
Drug Screening (1974-1987)
Neoplasms, Experimental or specific (1966-1987)
Tumor Stem Cell Assay (1984-1987)
Public MeSH Note
88
History Note
88
Date Established
1988/01/01
Date of Entry
1987/05/08
Revision Date
2015/06/22
Drug Screening Assays, Antitumor Preferred
Dye Exclusion Assays, Antitumor Narrower
page delivered in 0.138s